core protein ccc DNA disruptor (Assembly Biosciences/Door Pharmaceuticals)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namecore protein ccc DNA disruptor (Assembly Biosciences/Door Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAssembly Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDoor Pharmaceuticals LLCAssembly Biosciences Inc
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A